Categories: Momentum Trader Alert HotlinesStock Market News

Doubling Up on the Pharmaceuticals Sector

Biotech and pharmaceutical stock have broken out to the upside over the past week or so.

This is perhaps most visible by the 13.15% gain recorded in your AbbVie (ABBV) shares over the past five days.

This week’s new Momentum Trader Alert recommendation is another closely related stock in this red hot sector: Abbot Laboratories (ABT).

Founded in 1888 and headquartered in North Chicago, Illinois, Abbot Laboratories (ABT) is a global health care company that develops a wide range of health care products and technologies. The company has a portfolio of leading, science-based offerings in diagnostics, medical devices, nutritional and branded generic pharmaceuticals.

Abbott Laboratories (ABT) versus the S&P 500 year to date

Momentum Trader Alert Analysis

Recommendation

Buy Abbott Laboratories (ABT) at market today and place your stop at $48.00.

I am holding off on recommending any options on this position after last Friday’s big jump.

Portfolio Update

Sell your remaining AbbVie (ABBV) November $70 calls for a 413% gain.

Raise your stop in ABBV’s stock to $83.80 to lock in at least a 20% gain.

Sell your remaining Intuitive Surgical, Inc. (ISRG) October $920 calls for a triple-digit-percentage gain.

Raise your stop in ISRG’s stock to $1,010.00 to lock in at least a 15% gain.

Raise your stop in CBOE Holdings Inc. (CBOE) to $101.05 to lock in at least a 10% gain in the stock.

You were stopped out of United Technologies (UTX) last week at a loss.

Sincerely,

Nicholas A. Vardy

Exclusive 5 Reasons Bitcoin Will Defy Market Expectations

Nicholas Vardy

Nicholas Vardy has a unique background that has proven his knack for making money in different markets around the world. He was the Editor of The Global Guru, a free weekly e-newsletter, and also edited the trading services Momentum Trader Alert, which focused on making short-term profits in the hottest markets in the world, and The Alpha Algorithm, which was designed specifically to deliver big, fast triple-digit winners, month after month. He was also the editor of Smart Money Masters, a monthly service focused on longer term investments recommended by the brightest minds in the business. Mr. Vardy has been a regular commentator on CNN International and the Fox Business Network. He has also published articles in The New Republic, The World and I, and The Baker & McKenzie Legal Review. The Global Guru/Nicholas Vardy has been cited in The Wall Street Journal, Newsweek, Fox Business News, CBS MarketWatch, Yahoo! Finance, and MSN Money Central. Mr. Vardy graduated from Stanford with a B.A. — with honors and distinction — in both Economics and History, and he also earned an M.A in Modern European Intellectual History. After winning a Fulbright Scholarship, he earned a J.D. degree at Harvard Law School where he was an editor of the Harvard International Law Journal. When not uncovering investment opportunities for his subscribers and investors, Mr. Vardy is a keep-fit enthusiast and an avid student of classical music.